Progyny Valuation

PGNY Stock  USD 38.15  0.16  0.42%   
At this time, the company appears to be undervalued. Progyny holds a recent Real Value of $41.06 per share. The prevailing price of the company is $38.15. Our model determines the value of Progyny from analyzing the company fundamentals such as Shares Outstanding of 96.5 M, return on equity of 0.13, and Operating Margin of 0.05 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support acquiring undervalued entities and dropping overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Price Book
6.6294
Enterprise Value
3.3 B
Enterprise Value Ebitda
51.4575
Price Sales
3.3934
Forward PE
53.4759
Undervalued
Today
38.15
Please note that Progyny's price fluctuation is very steady at this time. Calculation of the real value of Progyny is based on 3 months time horizon. Increasing Progyny's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Progyny is useful when determining the fair value of the Progyny stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Progyny. Since Progyny is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Progyny Stock. However, Progyny's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  38.15 Real  41.06 Target  49.14 Hype  38.19 Naive  40.41
The real value of Progyny Stock, also known as its intrinsic value, is the underlying worth of Progyny Company, which is reflected in its stock price. It is based on Progyny's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Progyny's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Progyny's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
41.06
Real Value
43.91
Upside
Estimating the potential upside or downside of Progyny helps investors to forecast how Progyny stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Progyny more accurately as focusing exclusively on Progyny's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.160.170.21
Details
Hype
Prediction
LowEstimatedHigh
35.3438.1941.04
Details
Naive
Forecast
LowNext ValueHigh
37.5640.4143.25
Details
10 Analysts
Consensus
LowTarget PriceHigh
44.7249.1454.55
Details

Progyny Investments

(102.87 Million)

Progyny Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Progyny's current stock value. Our valuation model uses many indicators to compare Progyny value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Progyny competition to find correlations between indicators driving Progyny's intrinsic value. More Info.
Progyny is regarded fourth in net asset category among related companies. It is regarded second in price to book category among related companies . The ratio of Net Asset to Price To Book for Progyny is about  114,130,992 . Price To Book Ratio is likely to drop to 6.43 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Progyny by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Progyny's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Progyny's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Progyny's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Progyny and how it compares across the competition.

About Progyny Valuation

The stock valuation mechanism determines the current worth of Progyny on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Progyny. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Progyny based exclusively on its fundamental and basic technical indicators. By analyzing Progyny's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Progyny's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Progyny. We calculate exposure to Progyny's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Progyny's related companies.
Last ReportedProjected for 2024
Gross Profit238.8 M250.7 M
Pretax Profit Margin 0.06  0.07 
Operating Profit Margin 0.06  0.06 
Net Profit Margin 0.06  0.06 
Gross Profit Margin 0.22  0.16 

8 Steps to conduct Progyny's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Progyny's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Progyny's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Progyny's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Progyny's revenue streams: Identify Progyny's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Progyny's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Progyny's growth potential: Evaluate Progyny's management, business model, and growth potential.
  • Determine Progyny's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Progyny's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Progyny Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Progyny does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding100.7 M
Quarterly Earnings Growth Y O Y3.645
Forward Price Earnings53.4759

Progyny Current Valuation Indicators

Valuation refers to the process of determining the present value of Progyny and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Progyny we look at many different elements of the entity such as Progyny's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Progyny's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Progyny's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Progyny, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Progyny's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Progyny's worth.
When determining whether Progyny offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Progyny's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Progyny Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Progyny Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Progyny Stock analysis

When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Progyny's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progyny. If investors know Progyny will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progyny listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
3.645
Earnings Share
0.62
Revenue Per Share
11.456
Quarterly Revenue Growth
0.26
Return On Assets
0.0598
The market value of Progyny is measured differently than its book value, which is the value of Progyny that is recorded on the company's balance sheet. Investors also form their own opinion of Progyny's value that differs from its market value or its book value, called intrinsic value, which is Progyny's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progyny's market value can be influenced by many factors that don't directly affect Progyny's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Progyny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Progyny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progyny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.